BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 1472761)

  • 1. Resialylation of sialidase-treated sheep and human erythrocytes by Trypanosoma cruzi trans-sialidase: restoration of complement resistance of desialylated sheep erythrocytes.
    Tomlinson S; Pontes de Carvalho L; Vandekerckhove F; Nussenzweig V
    Glycobiology; 1992 Dec; 2(6):549-51. PubMed ID: 1472761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of the masking effect of sialic acid groups on sialidase-treated erythrocytes by the action of sialyltransferases.
    Kelm S; Shukla AK; Paulson JC; Schauer R
    Carbohydr Res; 1986 Jun; 149(1):59-64. PubMed ID: 3089604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The developmentally regulated trans-sialidase from Trypanosoma brucei sialylates the procyclic acidic repetitive protein.
    Engstler M; Reuter G; Schauer R
    Mol Biochem Parasitol; 1993 Sep; 61(1):1-13. PubMed ID: 8259122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement.
    Tomlinson S; Pontes de Carvalho LC; Vandekerckhove F; Nussenzweig V
    J Immunol; 1994 Oct; 153(7):3141-7. PubMed ID: 8089492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of membrane-associated sialic acid in the resistance of sheep erythrocytes to lysis by mouse complement.
    Rademaker PM; van Dijk H; Willers JM
    Immunol Lett; 1981 Oct; 3(4):221-5. PubMed ID: 7309131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome.
    Ming M; Chuenkova M; Ortega-Barria E; Pereira ME
    Mol Biochem Parasitol; 1993 Jun; 59(2):243-52. PubMed ID: 8341323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma rangeli sialidase lacks trans-sialidase activity.
    Pontes-de-Carvalho LC; Tomlinson S; Nussenzweig V
    Mol Biochem Parasitol; 1993 Nov; 62(1):19-25. PubMed ID: 8114822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi.
    Colli W
    FASEB J; 1993 Oct; 7(13):1257-64. PubMed ID: 8405811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of constitutive and inducible trans-sialylation dominant-negative phenotypes in Trypanosoma brucei and Trypanosoma cruzi.
    Engstler M; Wirtz E; Cross GA
    Glycobiology; 1997 Oct; 7(7):955-64. PubMed ID: 9363438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of the Trypanosoma cruzi trans-sialidase.
    Vandekerckhove F; Schenkman S; Pontes de Carvalho L; Tomlinson S; Kiso M; Yoshida M; Hasegawa A; Nussenzweig V
    Glycobiology; 1992 Dec; 2(6):541-8. PubMed ID: 1282052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells.
    Schenkman S; Jiang MS; Hart GW; Nussenzweig V
    Cell; 1991 Jun; 65(7):1117-25. PubMed ID: 1712251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of sialic acid from mucin-like surface molecules of Trypanosoma cruzi metacyclic trypomastigotes enhances parasite-host cell interaction.
    Yoshida N; Dorta ML; Ferreira AT; Oshiro ME; Mortara RA; Acosta-Serrano A; Favoreto Júnior S
    Mol Biochem Parasitol; 1997 Jan; 84(1):57-67. PubMed ID: 9041521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
    Tertov VV; Kaplun VV; Sobenin IA; Boytsova EY; Bovin NV; Orekhov AN
    Atherosclerosis; 2001 Nov; 159(1):103-15. PubMed ID: 11689212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of Trypanosoma cruzi trans-sialidase on glycolipids and glycoproteins.
    Ferrero-García MA; Trombetta SE; Sánchez DO; Reglero A; Frasch AC; Parodi AJ
    Eur J Biochem; 1993 Apr; 213(2):765-71. PubMed ID: 8477749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase.
    Ribeirão M; Pereira-Chioccola VL; Eichinger D; Rodrigues MM; Schenkman S
    Glycobiology; 1997 Dec; 7(8):1237-46. PubMed ID: 9455925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary 1H NMR investigation of sialic acid transfer by the trans-sialidase from Trypanosoma cruzi.
    Wilson JC; Kiefel MJ; Albouz-Abo S; von Itzstein M
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2791-4. PubMed ID: 11133093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
    Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
    Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional properties of Trypanosoma trans-sialidase.
    Schenkman S; Eichinger D; Pereira ME; Nussenzweig V
    Annu Rev Microbiol; 1994; 48():499-523. PubMed ID: 7826016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay for sialidase using erythrocytes and peroxidase-labeled peanut lectin.
    Nagai T; Yamada H
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2243-4. PubMed ID: 2688936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.
    Libby P; Alroy J; Pereira ME
    J Clin Invest; 1986 Jan; 77(1):127-35. PubMed ID: 3080470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.